Figure 5.
PFS (A) and OS (B) by depth of response measured by degree of M-protein level reduction for patients assigned to POM + LoDEX. LoDEX: low-dose dexamethasone; OS: overall survival; PFS: progression-free survival; POM: pomalidomide.
PFS (A) and OS (B) by depth of response measured by degree of M-protein level reduction for patients assigned to POM + LoDEX. LoDEX: low-dose dexamethasone; OS: overall survival; PFS: progression-free survival; POM: pomalidomide.